Literature DB >> 31376875

General practitioners' views on the diagnostic innovations in DSM-5 somatic symptom disorder - A focus group study.

Marco Lehmann1, Christina Jonas2, Nadine Janis Pohontsch3, Thomas Zimmermann4, Martin Scherer5, Bernd Löwe6.   

Abstract

BACKGROUND: The innovations concerning the new diagnosis somatic symptom disorder (SSD) in the DSM-5 include the introduction of psychological diagnostic criteria and the elimination of the need to exclude all potential somatic causes of the symptoms. Thus far, it is unknown how general practitioners (GPs) evaluate the innovations conceptually and regarding their applicability in primary care.
METHOD: We performed six focus groups with GPs. A semi-structured interview-guideline included a presentation of the innovations of SSD and questions about the innovations and their potential (dis-)advantages from the GPs' points of view. The material was analyzed using structuring qualitative content analysis.
RESULTS: A total of 41 GPs participated (mean (sd) age = 51 (8.5) years, female = 17, male = 24). The GPs assessed that the diagnostic innovations could help them to focus on symptom-related concerns and anxiety as core aspects of the patients' complaints. However, the meaning of the term excessive in the psychological diagnostic criteria (i.e., excessive worries, anxiety, time and energy) was ambiguous for the GPs. The GPs appreciated that a mental disorder can be assigned in addition to a severe physical disease. The GPs found it unlikely that diagnostic workup of somatic symptoms would be cut short if the diagnostic criteria of SSD were fulfilled in a given patient.
CONCLUSION: Altogether, for the GPs, the advantages of the new diagnostic criteria for SSD outweighed the disadvantages. In particular, the newly included psychological criteria were seen as an important advancement in comparison to the previous need of merely excluding a physical disease.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31376875     DOI: 10.1016/j.jpsychores.2019.109734

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

1.  Diagnostic and treatment barriers to persistent somatic symptoms in primary care - representative survey with physicians.

Authors:  Marco Lehmann; Nadine Janis Pohontsch; Thomas Zimmermann; Martin Scherer; Bernd Löwe
Journal:  BMC Fam Pract       Date:  2021-04-01       Impact factor: 2.497

Review 2.  Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.

Authors:  Bernd Löwe; James Levenson; Miriam Depping; Paul Hüsing; Sebastian Kohlmann; Marco Lehmann; Meike Shedden-Mora; Anne Toussaint; Natalie Uhlenbusch; Angelika Weigel
Journal:  Psychol Med       Date:  2021-11-15       Impact factor: 7.723

3.  Estimated frequency of somatic symptom disorder in general practice: cross-sectional survey with general practitioners.

Authors:  Marco Lehmann; Nadine Janis Pohontsch; Thomas Zimmermann; Martin Scherer; Bernd Löwe
Journal:  BMC Psychiatry       Date:  2022-09-29       Impact factor: 4.144

4.  Patients With Somatoform Disorders Are Prone to Expensive and Potentially Harmful Medical Procedures—Results of a Retrospective Cohort Study Over 15 Years.

Authors:  Antonius Schneider; Ewan Donnachie; Stephan Zipfel; Paul Enck
Journal:  Dtsch Arztebl Int       Date:  2021-06-25       Impact factor: 5.594

5.  New challenges in the COVID-19 pandemic.

Authors:  Jess G Fiedorowicz
Journal:  J Psychosom Res       Date:  2020-04-22       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.